KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Free Cash Flow Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.29%
Dec 31, 2025 -13.46%
Sep 30, 2025 5.61%
Jun 30, 2025 -6.57%
Mar 31, 2025 -13.23%
Dec 31, 2024 13.60%
Sep 30, 2024 0.66%
Jun 30, 2024 11.83%
Mar 31, 2024 -23.30%
Dec 31, 2023 -37.24%
Sep 30, 2023 -4.13%
Jun 30, 2023 14.92%
Mar 31, 2023 -22.48%
Dec 31, 2022 -4.18%
Sep 30, 2022 -3.09%
Jun 30, 2022 -4.69%
Mar 31, 2022 -2.30%
Dec 31, 2021 -2.58%
Sep 30, 2021 -2.70%
Jun 30, 2021 -6.85%
Mar 31, 2021 1.96%
Dec 31, 2020 1.17%
Sep 30, 2020 3.26%
Jun 30, 2020 -3.16%
Mar 31, 2020 7.87%
Dec 31, 2019 -2.49%
Sep 30, 2019 4.52%
Jun 30, 2019 -9.17%
Mar 31, 2019 12.25%
Dec 31, 2018 12.69%
Sep 30, 2018 13.71%
Jun 30, 2018 5.85%
Mar 31, 2018 23.62%
Dec 31, 2017 36.11%
Sep 30, 2017 16.29%
Jun 30, 2017 -0.57%
Mar 31, 2017 21.77%
Dec 31, 2016 16.13%
Sep 30, 2016 24.06%
Jun 30, 2016 11.99%
Mar 31, 2016 13.59%
Dec 31, 2015 0.46%
Sep 30, 2015 18.57%
Jun 30, 2015 17.84%
Mar 31, 2015 10.74%
Dec 31, 2014 9.47%
Sep 30, 2014 6.86%
Jun 30, 2014 5.93%
Mar 31, 2014 5.51%